T1	Participants 96 179	healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene
T2	Participants 1458 1466	subjects
T3	Participants 1569 1807	Forty individuals participated in this two-part study: 20 asymptomatic porphobilinogen deaminase-deficient subjects (both male and female) with > or =4 times the upper reference urinary porphobilinogen level, and 20 healthy male subjects.